Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Junkang Pharmaceutical is a private Chinese pharmaceutical company focused on the development and manufacturing of generic drugs. It has conducted at least two bioequivalence clinical trials in China—one for aceclofenac tablets and another for pentoxifylline sustained-release tablets—demonstrating its capabilities in bringing generics to the Chinese market. Both trials were designed to compare their products with established reference drugs under fasting and fed conditions in healthy volunteers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Junkang Pharmaceutical.